黄芪注射液联合肌苷治疗急性病毒性心肌炎疗效观察

Therapeutic effect ot Huangqi injection combined with inosine on acute viral myocarditis

目的探讨黄芪注射液治疗急性病毒性心肌炎的临床疗效。方法将96例急性病毒性心肌炎(acute viralmyocarditis,AVM)患者随机分成治疗组(48例)和对照组(48例)。2组患者均予卧床休息、镇静,口服维生素C,极化液静脉滴注等治疗。治疗组在此基础上应用黄芪注射液50ml/d静脉滴注。口服肌苷0.4g,3次/d,2组疗程均为4周。比较2组疗效。结果治疗组有效率为92%,对照组为64%;治疗组疗效明显优于对照组(P<0.01),2组的不良反应发生率为6%,2组的不良反应发生率比较差异无统计学意义(P>0.05)。结论黄芪注射液联合肌苷对AVM有较好的疗效,且不良反应轻微。

Objective To observe the therapeutic effect of Huangqi injection on the treatment of acute viral myocarditis.MethodNinety-six patients were randomly divided into the treatment group and the control group,with 48 patients in ecah group.All patients were required to rest on bed and take sedatives and vitamin C and received polarized liquid intravenously.The patients in the treatment group were received Huangqi drip intravenously at a dose of 50ml/d and inosine orally at a dose of 0.4g fid per day.Both groups of patients were treated for 4 weeks.The differences of effect in the two groups were compared.ResultThe effective rate in the treatment group was 92% and that in the control group was 64%.The effective rate in the treatment group was higher than that in the control group（P0.01）.The incidence of adverse reaction in both group was 6% and there was no significance between the two groups（P0.05）.Conclusion Huangqi injection combined with inosine is effective in the treatment of acute viral myocarditis with less adverse reaction.